Rochester, Minn Clinical Profile


Morie A. Gertz, M.D., has research interests in amyloidosis and multiple myeloma. Particularly, Dr. Gertz studies relapse rates in patients with multiple myeloma and amyloidosis when being treated with novel versus traditional therapies.

Focus areas

  • Primary amyloidosis
  • Stem cell transplantation in the treatment of multiple myeloma
  • Amyloidosis
  • Waldenström's macroglobulinemia

Significance to patient care

The research findings of Dr. Gertz will lead to improved treatment for amyloidosis and multiple myeloma.

Professional highlights

  • Member, Committee on Training, American Society of Hematology, 2015-present
  • Member, Hematology Board Exam Committee, American Board of Internal Medicine, 2015-present
  • Recipient, Waldenström Award for medical and scientific achievements in Waldenström's macroglobulinemia, 2014
  • Treasurer, International Myeloma Society, 2011-2014
  • President, Mayo Staff Officers and Councilors, Mayo Clinic, 2005


See my publications


Academic Rank

  1. Professor of Medicine


  1. Fellow - Department of Hematology and Oncology Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  2. Resident - Internal Medicine Presbyterian-St. Luke's Medical Center
  3. Internship Presbyterian-St. Luke's Medical Center
  4. Internship St. Joseph's Hospital
  5. MD Loyola University & Stritch School of Medicine
  6. BA - Arts and Sciences Northwestern University

View my Pure Experts profile

Mayo Clinic Footer